Scholarlink

Background <p>Cluster modelling has demonstrated asthma heterogeneity across disease severities, but contemporary data integrating difficult-to-treat and mild asthma with systematic assessment of comorbidity-focused treatable traits remain limited.</p> Objective <p>To identify and characterise difficult-to-treat and mild asthma clusters in two UK cohorts: Wessex AsThma CoHort of Difficult Asthma (WATCH-DA) and a mild-asthma cohort from the Epigenetics of Severe Asthma study (EOSA-MA).</p> Methods <p>Separate K-means clustering was applied to WATCH-DA (<i>n</i> = 498; 11 variables) and EOSA-MA (<i>n</i> = 67; 12 variables). Post-hoc comparisons evaluated demographic, inflammatory, physiological, comorbidity and patient-reported outcome profiles.</p> Results <p>Six difficult-to-treat and two mild asthma clusters were identified respectively, all Type-2 (T2)-predominant. Difficult-to-treat asthma clusters differed by sex, age of asthma-onset, body mass index (BMI) and comorbidities. Two clinically controlled clusters, cluster-1 (Early-onset atopic controlled) and cluster-4 (Late-adult-onset non-atopic controlled), showed distinct comorbidity patterns despite lower overall morbidity. Three severe, exacerbation-prone, adult-onset, female predominant difficult-to-treat clusters (Adult-onset eosinophilic exacerbator [cluster-2], Young-adult-onset high-risk exacerbator [cluster-5], Adult-onset obese multimorbid symptomatic [cluster-6]) varied by blood eosinophil counts (BEC), spirometry, BMI, treatment needs, comorbidities, and quality of life. An Adolescent-onset obese atopic obstructive (cluster-3) showed fewer exacerbations but high BEC with worst spirometry and poor asthma control. In mild asthma, cluster-1 (Early-onset atopic mild) showed worse pathophysiological indices and asthma control than cluster-2 (Adolescent-onset mild) but similarly high comorbidity prevalence.</p> Conclusion <p>Characterisation of difficult-to-treat and mild asthma clusters reveals diverse associated clinical traits and outcomes across the asthma severity spectrum. Recognition of these clusters and their associated comorbidities should prompt early personalised asthma management to address both airway-centric and comorbid disease aspects.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical phenotypes of difficult-to-treat and mild asthma defined by cluster analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月29日

查看全文
  • Mohammad Leily,
  • Heena Mistry,
  • Hongmei Zhang,
  • Maria Larsson,
  • Judit Varkonyi-Sepp,
  • Ben Ainsworth,
  • Liuyu Wei,
  • Chellan Eames,
  • J. J. Hudson-Colby,
  • Adam Lewis,
  • Anna Freeman,
  • Hans Michael Haitchi,
  • Paddy Dennison,
  • Ratko Djukanovic,
  • Sara Herrera-De La Mata,
  • Grégory Seumois,
  • Pandurangan Vijayanand,
  • Mohammed A. Kyyaly,
  • Elena Vorobeva,
  • Elena Dabrio-Reina,
  • Syed Hasan Arshad,
  • Ramesh J. Kurukulaaratchy

摘要

Background

Cluster modelling has demonstrated asthma heterogeneity across disease severities, but contemporary data integrating difficult-to-treat and mild asthma with systematic assessment of comorbidity-focused treatable traits remain limited.

Objective

To identify and characterise difficult-to-treat and mild asthma clusters in two UK cohorts: Wessex AsThma CoHort of Difficult Asthma (WATCH-DA) and a mild-asthma cohort from the Epigenetics of Severe Asthma study (EOSA-MA).

Methods

Separate K-means clustering was applied to WATCH-DA (n = 498; 11 variables) and EOSA-MA (n = 67; 12 variables). Post-hoc comparisons evaluated demographic, inflammatory, physiological, comorbidity and patient-reported outcome profiles.

Results

Six difficult-to-treat and two mild asthma clusters were identified respectively, all Type-2 (T2)-predominant. Difficult-to-treat asthma clusters differed by sex, age of asthma-onset, body mass index (BMI) and comorbidities. Two clinically controlled clusters, cluster-1 (Early-onset atopic controlled) and cluster-4 (Late-adult-onset non-atopic controlled), showed distinct comorbidity patterns despite lower overall morbidity. Three severe, exacerbation-prone, adult-onset, female predominant difficult-to-treat clusters (Adult-onset eosinophilic exacerbator [cluster-2], Young-adult-onset high-risk exacerbator [cluster-5], Adult-onset obese multimorbid symptomatic [cluster-6]) varied by blood eosinophil counts (BEC), spirometry, BMI, treatment needs, comorbidities, and quality of life. An Adolescent-onset obese atopic obstructive (cluster-3) showed fewer exacerbations but high BEC with worst spirometry and poor asthma control. In mild asthma, cluster-1 (Early-onset atopic mild) showed worse pathophysiological indices and asthma control than cluster-2 (Adolescent-onset mild) but similarly high comorbidity prevalence.

Conclusion

Characterisation of difficult-to-treat and mild asthma clusters reveals diverse associated clinical traits and outcomes across the asthma severity spectrum. Recognition of these clusters and their associated comorbidities should prompt early personalised asthma management to address both airway-centric and comorbid disease aspects.